Dr Samuel Costello - MBBS FRACP PhD - TITLEHOLDER.Gastroenterologist Dr Costello graduated from medical school at the University of Adelaide in 2004 and then completed basic physician training at the Royal Adelaide Hospital followed by Gastroenterology training at The Queen Elizabeth Hospital and Repatriation general hospital. He undertook a clinical fellowship in inflammatory bowel disease at St Mark’s hospital in London in 2016.Dr Costello is a staff specialist at The Queen Elizabeth Hospital and a consultant with the inflammatory bowel disease service. He is the co-lead of IBD research at The Queen Elizabeth Hospital. Dr Costello established and continues to manage the South Australian faecal microbiota transplantation (FMT) service for the treatment of Clostridium difficile infection and has advised other groups in Australia and internationally about developing similar services. Dr Costello is passionate about medical research. He completed a PhD at the University of Adelaide where the focus of his research was FMT as a treatment for ulcerative colitis. He has published multiple papers in peer-reviewed international journals and has been an invited speaker at national and international conferences on the topics of FMT and microbial therapeutics. Dr Costello co-founded microbial therapeutics company BiomeBank in 2018, that supplies donor derived FMT product to Australian hospitals and is developing second generation defined microbial therapies. Dr Costello is Chief Medical Officer and a Director of BiomeBank. Sam enjoys teaching both medical students as well as doctors in training and is a clinical lecturer at the University of Adelaide.